Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2448 of 5804
-
New nerve block may keep arm strong after shoulder surgery
Symptom relief CompletedThe goal of this clinical trial is to learn if pericapsular nerve group block (PENG) in shoulder scope surgery provides adequate analgesia with less affection of muscle power compared to interscalene block. The main questions it aims to answer are: Does PENG block provide analge…
Phase: NA • Sponsor: Sherin Refaat • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New Bacteria-Based cream aims to soothe cancer drug rash
Symptom relief Recruiting nowThe goal of this randomized clinical trial is to learn if topical treatment with ATR04-484 can treat skin rash in patients undergoing EGFR inhibitor (EGFRi) therapy. The primary goal of the study is to determine safety and tolerability of ATR04-484, and the secondary goal of the …
Phase: PHASE1, PHASE2 • Sponsor: Azitra Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Health talks may keep seniors out of hospital
Prevention Recruiting nowThe HOME Project evaluates the effects of structured health dialogues with individuals aged 67-84 years in the municipality of Borgholm, Sweden. A combination of registry data and survey responses will be used to monitor quality of life, morbidity, healthcare needs, and lifestyle…
Phase: NA • Sponsor: Linkoeping University • Aim: Prevention
Last updated Jun 27, 2026 07:54 UTC
-
Could taking two prenatal supplements at once be just as good?
Disease control Recruiting nowThe World Health Organization (WHO) currently recommends the pregnant women receive iron-containing supplements and, in settings where calcium intake is low, calcium supplements. Supplements are to be taken at two separate times of the day as calcium may interfere with iron absor…
Phase: PHASE3 • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
App that scans food labels could help control diabetes
Disease control Recruiting nowThis randomized controlled trial will assess the impact of the FoodSwitch mobile app, which provides interpretive front-of-pack labelling via barcode scanning, in 900 Swedish adults with type 2 diabetes. Participants will be randomized to app + standard advice or standard advice …
Phase: NA • Sponsor: Linkoeping University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Massage and shower during labor may boost birth satisfaction
Symptom relief CompletedStudy Design This study is a quasi-experimental research designed to examine the effects of massage and warm shower-used as non-pharmacological methods during labor-on birth satisfaction, maternal comfort, and breastfeeding success. tudy Population The study was conducted in th…
Phase: NA • Sponsor: Sakarya University • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New pill aims to tame kidney disease in Long-Term trial
Disease control Recruiting nowThis is a Phase II, multicenter, open-label study. Eligible subjects who have completed the HSK39297-202 study will be enrolled.Starting dose is 200 mg QD.Dose may be increased to 300 mg QD after 8-12 weeks of stable 200 mg QD therapy if 24-h urine protein excretion (UPE) remains…
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New obesity drug XW003 tested in teens – early results show promise
Disease control CompletedThe aim of the study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of XW003 injection in Chinese adolescents with obesity
Phase: PHASE1 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for advanced cancer? SLV-324 enters first human trial
Disease control Recruiting nowThis is a Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of SLV-324 across a range of dose levels when administered to subjects with metastatic solid tumors.
Phase: PHASE1 • Sponsor: Solve Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a puff of inhaled epinephrine stop severe allergic reactions?
Symptom relief Recruiting nowThe goal of this exploratory study is to evaluate the effects of inhaled epinephrine in subjects, who may not be eligible for the GHL-101 trial, and who are experiencing systemic allergic reaction (SAR) that occur following allergy testing, subcutaneous immunotherapy (SCIT), oral…
Phase: PHASE1 • Sponsor: Dr. George Luciuk • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Freezing nerves could offer new hope for diabetic foot pain
Symptom relief OngoingThe study is a single-center, randomized, participant- and observer-masked, human-subjects, post-market clinical pilot study to investigate the use of ultrasound-guided percutaneous cryoneurolysis to treat diabetic neuropathy of the foot. A prolonged nerve block may be provided b…
Phase: NA • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Can a Low-Dose steroid tame Immunotherapy's liver side effect?
Disease control Recruiting nowThis study evaluates the effectiveness of low-dose corticosteroids in managing grade 2-3 immune-related hepatitis in cancer patients treated with immune checkpoint inhibitors. It aims to determine whether of 0.5-1miligram per kilogram bodyweight prednisolone is sufficient to mana…
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 26, 2026 16:53 UTC
-
Could sticky tape ease breast cancer swelling? new trial investigates
Symptom relief Recruiting nowThe goal of the KiTaLymph trial is to investigate whether the application of kinesio tape is effective in women with persistent (\>6 months) breast and/or truncal oedema after treatment for breast cancer. The main objectives are to assess whether kinesio taping: * reduces pain …
Phase: NA • Sponsor: Universiteit Antwerpen • Aim: Symptom relief
Last updated Jun 26, 2026 13:10 UTC
-
Glue or coils? new study aims to settle best fix for pelvic pain
Symptom relief ENROLLING_BY_INVITATIONFoam Plus Glue Versus Foam Plus Coils for Ovarian Vein Embolization in the Treatment of Pelvic Venous Disorders: A Randomized Controlled Trial
Phase: NA • Sponsor: Kafrelsheikh University • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Could a tiny ring improve cataract surgery for RP patients?
Disease control Recruiting nowThis is a self-controlled randomized clinical trial to investigate the effect of capsular tension ring (CTR) implantation on intraocular lens (IOL) position in cataract patients with retinitis pigmentosa(RP). Each patient will receive CTR implantation in one eye, with the fellow …
Phase: NA • Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Ultrasound could prevent deadly lung complications in preeclampsia
Diagnosis Recruiting nowThis research aims to evaluate the usefulness of lung ultrasound (LUS) for detecting and monitoring fluid overload in patients with severe preeclampsia. Severe preeclampsia is a leading cause of maternal death and illness worldwide, often causing fluid buildup that can lead to a …
Phase: NA • Sponsor: Saint Thomas Hospital, Panama • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Brain zaps for back pain: new study tests tACS
Symptom relief Recruiting nowInvestigating the modulation effect of tACS
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New combo therapy hopes to shrink spleens and ease symptoms in Tough-to-Treat myelofibrosis
Disease control Recruiting nowThe goal of this open-label, single-center, pilot trial is to test the combination of Tagraxofusp (TAG) with Pacritinib (PAC) in patients with intermediate-II or higher myelofibrosis (MF), who have had prior therapy with the approved JAK1/2 inhibitor or in which therapy with the …
Phase: EARLY_PHASE1 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New app aims to boost Well-Being in black men battling prostate cancer
Symptom relief Recruiting nowThe goal of this clinical trial is to ensure that the mobile health application for Black patients with prostate cancer (either actively undergoing treatment or survivors) is usable and acceptable to patients, get feedback about how to improve the app and assess its usefulness in…
Phase: NA • Sponsor: University of Oklahoma • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New drug aims to stop blood clots during dialysis
Disease control Recruiting nowThe primary objective of this study is to assess the safety and tolerability of KN060 in patients with end-stage renal disease on regular hemodialysis. The secondary objectives to evaluate the pharmacokinetic and pharmacodynamic properties of multiple doses of KN060; to evaluate…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Alphamab Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC